<DOC>
	<DOCNO>NCT01983943</DOCNO>
	<brief_summary>The purpose study conduct double-blind , randomize control trial ( RCT ) , determine six month supplementation olive oil improve health blood vessel improve long term health heart blood vessel , patient require percutaneous coronary intervention ( PCI ) .</brief_summary>
	<brief_title>Olive Oil Cardiovascular Health</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>3,4-dihydroxyphenylethanol</mesh_term>
	<mesh_term>Phenylethyl Alcohol</mesh_term>
	<criteria>Subjects include follow 1 . Age ≥ 18 year old 2 . Have know diagnosis coronary artery disease 3 . Demonstrated endothelial dysfunction ( reactive hyperemia EndoPAT score &lt; 2.0 ) time screen Patient exclusion criterion : Patients exclude one following : 1 . Hypertension ( Screening ) : patient systolic blood pressure ( SBP ) ≥ 170 mmHg diastolic blood pressure ≥ 110 mmHg , hypotension ( SBP &lt; 100 mmHg ) 2 . Uncontrolled Diabetes Mellitus 3 . Experienced acute coronary syndrome within 3 month 4 . PCI revascularization acute coronary syndrome within 3 month 5 . Second ( II ) third ( III ) degree heart block without pacemaker and/or concurrent potentially life threaten arrhythmia uncontrolled arrhythmia 6 . Congestive heart failure NYHA class III IV 7 . Unstable serum creatinine ( &gt; 2.0 ) 8 . Any surgical medical condition might significantly alter absorption , distribution , metabolism , excretion olive oil include , limited , follow : History major gastrointestinal tract surgery gastrectomy , gastroenterostomy , bowel resection Any history pancreatic injury , pancreatitis evidence impair pancreatic function/injury indicate abnormal lipase amylase Evidence hepatic disease determine history hepatic encephalopathy , history cirrhosis , esophageal varix , history portocaval shunt 9 . Any concurrent life threaten condition life expectancy le 2 year 10 . History evidence drug alcohol abuse within last 12 month 11 . History hypersensitivity study drug medication belong therapeutic class study drug well know suspect contraindication study drug 12 . History noncompliance medical regimen unwillingness comply study protocol 13 . History malignancy basal cell skin cancer within past five year 14 . Any surgical medical condition , opinion investigator , may place patient high risk his/her participation study , likely prevent patient comply requirement study complete study 15 . Use investigational drug time enrollment , within 30 day 5 halflives enrollment , whichever longer 16 . Any condition opinion investigator would jeopardize evaluation efficacy safety 17 . Persons directly involved execution protocol 18 . Pregnant nursing ( lactate ) woman 19 . Women childbearing potential unless postmenopausal least one year , surgically sterile use effective method contraception define local Health Authorities</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>